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Protocol
AbstrACt
Introduction Women, their Offspring and iMproving 
lifestyle for Better cardiovascular health of both 
(WOMB) project is the follow-up of the LIFEstyle study, 
a randomised controlled trial in obese infertile women, 
and investigates the effects of a preconception lifestyle 
intervention on later health of women (WOMB women) and 
their children (WOMB kids).
Methods and analysis Obese infertile women, aged 
between 18 and 39 years, were recruited in 23 Dutch 
fertility clinics between June 2009 and June 2012. The 
284 women allocated to the intervention group received a 
6-month structured lifestyle programme. The 280 women 
in the control group received infertility care as usual. 4 
to 7 years after inclusion in the trial, all women (n=564) 
and children conceived during the trial (24 months after 
randomisation) (n=305 singletons and age 3–5 years) 
will be approached to participate in this follow-up study 
(starting in 2015). The main focus of outcome will be 
cardiovascular health, but the dataset comprises a wide 
range of physical and mental health measures, diet and 
physical activity measures, child growth and development 
measures, biological samples and genetic and epigenetic 
information. The follow-up assessment consists of three 
stages that take place between 2016 and 2018, and 
includes (online) questionnaires, accelerometry and 
physical and behavioural measurements in a mobile 
research vehicle. A subsample of 100 women and 100 
children are planned for cardiac ultrasound measurements.
Ethics and dissemination The protocol of this follow-up 
study is approved by the local medical ethics committee 
(University Medical Centre Groningen). Study findings 
of the WOMB project will be widely disseminated to the 
scientific community, healthcare professionals, policy 
makers, future parents and general public.
trial registration number The original LIFEstyle study is 
registered at The Netherlands Trial Registry (number 1530).
IntroduCtIon  
The overall aim of the Women, their 
Offspring and iMproving lifestyle for Better 
cardiovascular health of both (WOMB) 
project is to examine the effects of a precon-
ception lifestyle intervention on health 
in obese women (WOMB women) and 
their children (WOMB kids). It concerns a 
follow-up of the LIFEstyle study, a multicentre 
randomised controlled trial (RCT) (Nether-
lands Trial Registry number 1530), that was 
originally set up to investigate the effects and 
costs of a structured lifestyle programme in 
overweight and obese infertile couples to 
prevent unnecessary infertility treatment and 
improve reproductive outcome.1 Compared 
with prompt infertility treatment, the LIFE-
style intervention did not increase the 
healthy singleton live birth rate, although it 
did raise the chance of spontaneous concep-
tion.2 Furthermore, live birth rate was higher 
strengths and limitations of this study
 ► The main strength of the Women, their Offspring 
and iMproving lifestyle for Better cardiovascular 
health of both project is the fact that it concerns 
the follow-up of a randomised controlled trial in 
which a structured lifestyle intervention was given 
preconceptionally.
 ► This study provides the opportunity to study the 
long-term health effects of the intervention on the 
mother and the prenatal programming effects on 
her child.
 ► Reasons to be cautious: attrition will lead to a 
reduction in power, and there may be selective 
attrition reducing the representativeness of the 
study sample.
 ► The LIFEstyle study women were included as patients 
with infertility problems which inevitably leads to 
limitations with respect to the generalisability of the 
findings to the obese female population in general.
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in women who succeeded in losing weight.3 Currently, 
4–7 years after the LIFEstyle study, we will investigate the 
effects of the intervention on women’s and offspring’s 
lifestyle and health, with specific focus on cardiovascular 
health.
Overweight and obese women have a higher risk of 
developing cardiovascular diseases (CVD) compared with 
normal weight women.4 They also have a higher chance 
of medical and obstetric complications during pregnancy, 
such as gestational hypertension, pre-eclampsia and 
gestational diabetes.5 The cardiovascular and metabolic 
health of women before and during pregnancy may influ-
ence the development of cardiovascular structure and 
function, and metabolic balance in the offspring, either 
mediated by increased risk of obstetric complications or 
by affecting placental and foetal growth and physiology.6 
Through these pathways, obese women may transfer 
the obesity risk to their children by non-Mendelian, for 
example, epigenetic, mechanisms.7
This intergenerational cycle of obesity and consequent 
susceptibility for non-communicable diseases (NCDs), 
including CVD, may be broken by improving the health 
of obese women before and during pregnancy, making 
a preconceptional lifestyle intervention the ideal window 
to improve the health of the current and subsequent 
generations.8 In general, women are especially recep-
tive to advice about lifestyle before and during preg-
nancy9 10 and optimising their lifestyle for the benefit 
of their offspring’s health will be a powerful motivator. 
Therefore, lifestyle interventions before and during preg-
nancy may be more effective than lifestyle interventions 
at any other time during the lifespan. Optimising life-
style of women before and during pregnancy may be an 
innovative way of improving cardiovascular health and 
preventing CVD both in women and in their offspring. 
The design of the LIFEstyle study creates a unique oppor-
tunity to investigate the long-term effects of preconcep-
tion lifestyle advice to overweight and obese women.
Figure 1 The LIFEstyle flow diagram: recruitment and study design.
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The LIFEstyle study was performed within the Dutch 
Consortium for Healthcare Evaluation and Research in 
Obstetrics and Gynaecology. The WOMB project will 
be carried out in a collaboration between the Academic 
Medical Centre (coordinating centre), the VU University 
Medical Centre, the University Medical Centre Gron-
ingen and Wageningen University and Research.
MEthods And AnAlysIs
In the following section, we will adhere to the Strength-
ening the Reporting of Observational Studies in Epide-
miology (STROBE) guidelines to the extent to which it 
is possible in a cohort profile. More details on handling 
of (quantitative) variables and statistical analyses will 
be provided in the papers describing the findings; the 
STROBE guidelines will be followed in papers resulting 
from this study.11
The WOMB cohort consists of women who partici-
pated in the LIFEstyle study (WOMB women) and their 
offspring (WOMB kids).
Participants WoMb women
Between June 2009 and June 2012, women were recruited 
for the LIFEstyle study at fertility clinics of six university 
medical centres and 17 general hospitals, spread over 
Table 1 Baseline characteristics of eligible participants and participants lost to attrition for WOMB women, according to trial 
group*
Characteristics†












  Age (years): mean±SD 28.8±4.5 25.8±3.4 29.8±4.6 30.4±4.8
  Caucasian‡ 249 (88.9) 8 246 (86.6) 1
  Education
   Primary school (4–12 years) 16 (5.7) 1 9 (3.2) 1
   Secondary education 67 (23.9) 1 63 (22.2) 1
   Intermediate vocational education 129 (46.1) 7 131 (46.1) 0
   Higher vocational education and university 55 (19.6) 1 69 (24.3) 1
   Unknown 13 (4.6) 0 12 (4.2) 0
  Smoker 72 (25.7) 5 60 (21.1) 0
  Nulliparous 218 (77.9) 9 215 (75.7) 2
  Duration of time attempting to conceive (months): 
median (IQR)
22.0 (14.0–36.0) 26.5 19.0 (13.0–32.5) 22.0
  BMI, median (IQR) 36.0 (33.4–38.5) 34.7 36.0 (33.5–38.2) 39.8
Characteristics of male partner
  Age (years), mean±SD 33.6±6.1 31.1±4.7 33.6±6.2 36.7±9.8
  BMI, median (IQR) 27.7 (24.5–31.0) 26.4 27.2 (24.2–31.0) 26.0
Infertility diagnosis§
  Female factor: anovulation 123 (43.9) 5 140 (49.3) 1
  Female factor: other 19 (6.8) 10 22 (7.7) 0
  Male factor 65 (23.2) 2 64 (22.5) 0
  Unexplained 84 (30.0) 3 77 (27.1) 2
PCOS
  PCOS (Rotterdam criteria): number/total number (%)¶ 93/123 (75.6) 4/5 104/140 (74.3) 0/1
Differences between the eligible intervention group and the eligible control group were compared with the use of Student’s t-test for means, 
Mann-Whitney U test for medians and χ2 test or Fisher’s exact test for proportions. There were no significant differences between the groups.
*Baseline is at randomisation for the LIFEstyle study.
†Number (%) unless otherwise specified.
‡Ethnic background was self-reported.
§Couples could have more than one diagnosis.
¶The denominator is the number of women with anovulatory infertility.
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The Netherlands. Women, aged between 18 and 39 years, 
who presented with infertility and a body mass index 
(BMI) ≥29 kg/m² could be included in the study. Women 
were diagnosed with infertility because of chronic anovu-
lation, oligomenorrhoea or amenorrhoea or, in case of a 
functioning ovulatory cycle, unsuccessful conception for 
at least 12 months. Exclusion criteria were severe endome-
triosis, premature ovarian insufficiency, endocrinopathy 
(eg, diabetes type I and Cushing’s syndrome), the use 
of donor semen because of azoospermia and untreated 
preconceptional hypertension or hypertension-related 
complications in a previous pregnancy.
Of the 822 eligible women, 577 agreed to participate and 
were randomly assigned to the intervention or the control 
group after providing written informed consent. Three 
women withdrew informed consent later on and 10 women 
were lost to follow-up, leaving 280 women in the control 
group and 284 women in the intervention group (figure 1). 
See table 1 for baseline characteristics of both groups.
The 284 women allocated to the intervention group 
received a 6 months structured lifestyle programme aiming 
at 5%–10% loss of their original body weight. During this 
weight loss period, they did not receive infertility treatment. 
The programme was developed according to National Insti-
tutes of Health12 recommendations during a single centre 
pilot study.13 14 The participants were guided by trained 
coaches with a degree in nursing or dietetics. Women were 
stimulated to reduce energy intake by 600 kcal/day (with a 
minimum total intake of 1200 kcal/day), supported by an 
online diet diary.15 They were also encouraged to increase 
physical activity, aiming at 10 000 steps per day, monitored 
by a step counter, and at least 30 min of exercise of moderate 
intensity two or three times a week. Furthermore, the coaches 
provided individualised motivational counselling, directed 
at awareness of healthy lifestyle and formulating goals. The 
intervention was terminated earlier if women became preg-
nant. In case of a miscarriage, women could resume the 
intervention. To enhance compliance with the intervention, 
the infertility treatment was offered as soon as women had 
reached minimal 5% wt loss or a BMI <29 kg/m².
The 280 women in the control group received infer-
tility treatment according to the Dutch infertility guide-
lines, irrespective of their BMI.
In total, 564 women will be eligible for the follow-up 
measurements of WOMB women.
Participants WoMb kids
The study population comprises all children of the 564 
women eligible for follow-up who were conceived within 
24 months after inclusion in the study. In total, 341 chil-
dren were born of whom 7 children died antepartum, 
during or short after labour. After exclusion of the chil-
dren from multiple pregnancies (n=29), 305 singletons 
will be eligible for WOMB kids (figure 2).
Figure 2 Flow diagram enrolment WOMB women and WOMB kids. WOMB, Women, their Offspring and iMproving lifestyle for 
Better cardiovascular health of both.
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What has been measured in the lIFEstyle study?
In the LIFEstyle study, information was obtained about 
demographics, medical, gynaecological and obstetric 
history, anthropometry, blood pressure, preconceptional 
lifestyle, eating behaviour, infertility treatment, preg-
nancy outcome, quality of life and medical costs of the 
intervention. Blood samples were taken and weight was 
measured at 0, 3 and 6 months after entering the study. In 
the intervention group, step counters and dietary assess-
ments were used during the 6 months of the interven-
tion. The majority of these data was collected during the 
6 months after inclusion in the study. Key measures are 
summarised in table 2.
WoMb project: planned follow-up assessments
In the WOMB project, data will be collected about present 
lifestyle, and mental and physical health, with a specific 
focus on cardiovascular health. An overview of all key 
measures is given in table 3 (WOMB women) and table 4 
(WOMB kids).
The follow-up assessment consists of three stages (flow-
chart in figure 3) and comprises of (online) question-
naires (focusing on physical and mental health, diet, 
sleep of woman and child and growth and development 
of the child), accelerometry, physical measurements and 
collection of biospecimens (blood, faeces and buccal 
swab samples) as well as child behavioural observations. 
A subsample of 100 women and 100 children are planned 
for in depth cardiovascular measurements, including 
intima–media thickness and ultrasound assessment of 
cardiac function.
The physical measurements and observations are done 
in a mobile research vehicle in the vicinity of the partic-
ipants’ homes to optimise participation and collect the 
data in a standardised situation.
statistical methods and power analyses
Following the RCT design, we will examine the effect of 
the preconception lifestyle intervention on later lifestyle 
and health of the women and their offspring by means of 
intention-to-treat analyses. In addition, we will perform per- 
protocol analyses in which women who did not complete 
the intervention will be excluded. Finally, the registered 
variations in adherence to the prescribed lifestyle inter-
vention will allow us to also perform exploratory dose–
response analyses in which associations between measures 
of variation in diet (eg, fruit/vegetable intake, soft drink 
intake and snack intake) or physical activity (eg, weekly 
moderate to vigorous physical activity) will be linked to 
outcomes (blood pressure, glucose/lipid levels, weight, 
child development and health) in both short and long 
term for women and their children. Furthermore, we will 
investigate whether physical, psychological, socioeconomic 
or genetic characteristics contribute to the effectiveness of 
Table 2 Measurements of LIFEstyle study 
Measures Timing of assessment* Data type
Demographic variables 
(also of partner)
Age, ethnicity, education level and smoking 
status
0 Self-reported
General health Medical history 0 Medical record
Quality of life 0 + 12 + 24 + 52 Self-reported
Anthropometrics Hip and waist circumference and weight 0 +12 + 24 Physical examination
Cardiometabolic health Blood pressure, glucose and insulin levels, 
lipid profile, inflammatory markers and 
hormone profile
0 +12 + 24 Physical examination
Lifestyle Eating behaviour 0 Self-reported
Diet (frequency and portion sizes, kcal)† 0 + 12 + 24 + 52 Self-reported
Physical activity 0 + 12 + 24 + 52 Self-reported 
and measured by 
pedometer† 
Reproductive health Previous pregnancies, anovulation, PCOS, 
infertility and gynaecological history
0 Self-reported and 
medical record
Method of conception, infertility treatments 
and complications 
0-104 Medical record 
Pregnancy outcomes Complications (gestational and postpartum 
maternal), foetal or neonatal outcomes and 
complications
Gestational weight gain






Economic evaluation Medical costs 0–104 (or 6 weeks after 
birth in case of pregnancy)
Medical record
*Number of weeks after inclusion, 0=baseline.
†Till 24 weeks in intervention group only.
PCOS, polycystic ovary syndrome.
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the intervention, giving insight into potential gene–envi-
ronment interactions, personality factors or susceptible 
socioeconomic groups and ultimately allowing us to refine 
and personalise future lifestyle intervention programmes to 
maximally target specific groups.
The main strength of the WOMB project is the fact that 
it concerns the follow-up of a RCT in which a structured 
lifestyle intervention was given preconceptionally. We will 
capitalise on the randomised design in which interference 
by other factors, like genetic variability and environmental 
characteristics, will be balanced between the intervention 
and the control arm. Inevitably, there will be loss to follow-up, 
since it is 4–7 years ago that the women were included in 
the LIFEstyle study. In general, attrition will lead to a reduc-
tion in power, and there may be selective attrition reducing 
the representativeness of the study sample.16 To control 
for selection bias, we will always report on the baseline 
characteristics of those who did and did not participate in 
Table 3 Planned measurements of WOMB women
Phase Measures Data type
4–7 years after 
lifestyle intervention
Demographic variables Information about current civil status, work and 
partner
Self-reported
General health Diseases/health problems, medication hospital 
admissions and quality of life
Self-reported
Anthropometrics Hip, waist and upper arm circumference, height and 
weight
Physical examination
Body composition Lean body mass, fat mass and total body water Physical examination
Cardio metabolic health Blood pressure, heart rate, arterial stiffness, ECG, 
physical condition, glucose and insulin levels, lipid 
profile and inflammatory markers
Physical examination
Reproductive health Reproductive history, symptoms PCOS and sexual 
health
Self-reported
Mental health Anxiety and depression, personality, stress, sleep, 
traumatic life events and social support
Self-reported




Physical activity Measured by 
accelerometer and self-
reported
PCOS, polycystic ovary syndrome; WOMB, Women, their Offspring and iMproving lifestyle for Better cardiovascular health of both.
Table 4 Planned measurements of WOMB kids
Phase Measures Data type
Between 
birth and age 
3–5 years
Growth Height, weight and head circumference Registration municipal youth 
healthcare visits
General health Diseases/health problems, medication and 
hospital admissions
Parent reported
Age 3–5 years Demographic variables Parent reported
Anthropometrics Hip, waist and upper arm circumference, height 
and weight.
Physical examination
Body composition Lean body mass, fat mass and total body water Physical examination
Cardiometabolic health Blood pressure, heart rate, arterial stiffness, 
glucose and insulin levels, lipid profile and 
inflammatory markers
Physical examination
General development Parent reported
Cognitive and behavioural 
development
Executive functioning, psychosocial skills and 
problems, sleep pattern and eating behaviour
Parent reported
Self-control Observed in laboratory setting
Lifestyle Diet Parent reported
Physical activity Measured by accelerometer
WOMB, Women, their Offspring and iMproving lifestyle for Better cardiovascular health of both.
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follow-up. The original study was not powered on long-term 
outcome of the women in advance, let alone the follow-up 
of their offspring, neither was it powered on cardiovascular 
outcomes. Therefore, we conducted power analyses with 
respect to the main outcome BMI, which can be considered 
a risk factor for later CVD.17 18 With respect to BMI, we need 
90 women in each arm (31.9% of the total population) to 
detect a 0.5 kg/m2 difference (27.5 kg/m2 vs 28 kg/m2) with 
a power of 80% (alpha level of 5% and an SD of 1.2). For the 
children, the participation rate needs to be higher: 70.1% 
(214 children), to detect a comparable difference (15.3 kg/
m2 vs 15.8 kg/m2) with the same power (alpha level of 5% 
and an SD of 1.3). All in all, power to detect meaningful 
differences between the groups, especially with respect to 
secondary outcomes, will depend on the attrition levels. To 
increase power and generalisability, we are planning to pool 
data with other studies that use a comparable conceptual 
framework and an equivalent design and implementation19 
(of which the Finnish RADIEL study is one20).
Ethics and dissemination
Ethics and safety considerations
The study will be conducted according to the princi-
ples of the Declaration of Helsinki (revised version of 
October 2013) and in accordance with the Dutch Medical 
Research Involving Human Subjects Act.
For WOMB women and WOMB kids separate written 
informed consents will be obtained, as well as for each 
follow-up stage. The participants and/or parents will be 
asked to sign a separate consent form to store biological 
material in the biobank for up to 50 years. The data will 
be handled confidentially and analysed coded, in compli-
ance with the Dutch Personal Data Protection Act.
The study imposes no risks on the participants. Taking 
a venous blood sample (women 40 mL and children 
15 mL) can be a small discomfort for the participants, but 
is considered safe. In the informed consent, the partici-
pants/parents have the ability to choose to participate in 
the study without blood sampling.
Dissemination
The study findings of the WOMB project will be widely 
announced and reported to the scientific community, 
healthcare professionals, policy makers, future parents 
and general public. Dissemination is crucial in actually 
achieving the ultimate goal of WOMB project to prevent 
CVD in two generations by optimising lifestyle of women 
before and during pregnancy.
The project has a Dutch website mainly focused on 
participants and a scientifically orientated interna-
tional website (http:// womb- project. eu/). In 2015, 
we started a social media community on Facebook 
(http://www.facebook/hetwombproject), primarily 
directed to Dutch women in the reproductive age 
group, with the goal to maximally reach our target 
population at the time that results of the study will be 
known (2018/2019). This community is regularly fed 
by interesting news facts, short films about our project, 
blogs of our researchers and guest blogs of other stake-
holders. We will also specifically focus on the dissemi-
nation of the study results among nutritionists, general 
practitioners, midwives and gynaecologists, who are in 
Figure 3 Flowchart follow-up assessment of WOMB project. WOMB, Women, their Offspring and iMproving lifestyle for Better 
cardiovascular health of both.
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the position to advice (future) pregnant women about 
(pre)conceptional lifestyle.
ConClusIon
The results of the present ongoing WOMB project, the 
follow-up of the LIFEstyle study, will show us if a precon-
ception lifestyle intervention can have long-term health 
benefits for obese women and their children. The project 
will also provide more detailed information about the rela-
tionship between preconceptional diet and physical activity 
and later health: for the women, but also with respect to the 
prenatal programming effect on the conceived children. In 
general, this project will bring forth new knowledge on the 
prevention of obesity and our opportunities of breaking the 
intergenerational cycle of obesity and consequent suscepti-
bility for NCDs, including CVD.
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